dcterms.isReferencedBy |
Creager, M.A., Luscher, T.F., Cosentino, F., Beckman, J.A., Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: Part I (2003) Circulation, 108 (12), pp. 1527-1532. , DOI 10.1161/01.CIR.0000091257.27563.32; Hayat, S.A., Patel, B., Khattar, R.S., Malik, R.A., Diabetic cardiomyopathy: Mechanisms, diagnosis and treatment (2004) Clinical Science, 107 (6), pp. 539-557. , DOI 10.1042/CS20040057; Adeghate, E., Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review (2004) Molecular and Cellular Biochemistry, 261 (1), pp. 187-191. , DOI 10.1023/B:MCBI.0000028755.86521.11; Zhi, Y.F., Prins, J.B., Marwick, T.H., Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications (2004) Endocrine Reviews, 25 (4), pp. 543-567. , DOI 10.1210/er.2003-0012; Gonzalez-Vilchez, F., Ayuela, J., Ares, M., Pi, J., Castillo, L., Martin-Duran, R., Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients (2005) International Journal of Cardiology, 101 (1), pp. 53-58. , DOI 10.1016/j.ijcard.2004.03.009; Aronson, D., Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes (2003) Journal of Hypertension, 21 (1), pp. 3-12. , DOI 10.1097/00004872-200301000-00002; From, A.M., Scott, C.G., Chen, H.H., Changes in diastolic dysfunction in diabetes mellitus over time (2009) Am J Cardiol, 103, pp. 1463-1466. , 10.1016/j.amjcard.2009.01.358. 19427447; Tenenbaum, A., Motro, M., Fisman, E.Z., Leor, J., Boyko, V., Mandelzweig, L., Behar, S., Status of glucose metabolism in patients with heart failure secondary to coronary artery disease (2002) American Journal of Cardiology, 90 (5), pp. 529-532. , DOI 10.1016/S0002-9149(02)02529-8, PII S0002914902025298; Takeshita, F., Kodama, M., Yamamoto, H., Ikarashi, Y., Ueda, S., Teratani, T., Yamamoto, Y., Quinn, G., Streptozotocin-induced partial beta cell depletion in nude mice without hyperglycaemia induces pancreatic morphogenesis in transplanted embryonic stem cells (2006) Diabetologia, 49 (12), pp. 2948-2958. , DOI 10.1007/s00125-006-0432-z; Rizzo, G., Fiorucci, S., PPARs and other nuclear receptors in inflammation (2006) Curr Opin Pharmacol, 6 (4), pp. 421-427. , 10.1016/j.coph.2006.03.012. 16777482; Ikebukuro, K., Adachi, Y., Yamada, Y., Fujimoto, S., Seino, Y., Oyaizu, H., Hioki, K., Ikehara, S., Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats (2002) Transplantation, 73 (4), pp. 512-518; Yu, S., Reddy, J.K., Transcription coactivators for peroxisome proliferator-activated receptors (2007) Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1771 (8), pp. 936-951. , DOI 10.1016/j.bbalip.2007.01.008, PII S138819810700011X; Bishop-Bailey, D., Peroxisome proliferator-activated receptors in the cardiovascular system (2000) Br J Pharmacol, 129, pp. 823-834. , 10.1038/sj.bjp.0703149. 10696077; Collin, M., Thiemermann, C., The PPAR-? ligand 15-deoxy?12,14 prostaglandin J2 reduces the liver injury in endotoxic shock (2003) European Journal of Pharmacology, 476 (3), pp. 257-258. , DOI 10.1016/S0014-2999(03)02179-4; Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Patel, N.S., Paola, R.D., Genovese, T., Thiemermann, C., Rosiglitazone and 15-deoxy-{Delta}12,14-prostaglandin J2, ligands of the peroxisome proliferator-activat (2003) Br J Pharmacol, 140, pp. 366-376. , 10.1038/sj.bjp.0705419. 12970094; Gilde, A.J., Van Bilsen, M., Peroxisome proliferator-activated receptors (PPARS): Regulators of gene expression in heart and skeletal muscle (2003) Acta Physiologica Scandinavica, 178 (4), pp. 425-434. , DOI 10.1046/j.1365-201X.2003.01161.x; Khandoudi, N., Delerive, P., Berrebi-Bertrand, I., Buckingham, R.E., Staels, B., Bril, A., Rosiglitazone, a peroxisome proliferator-activated receptor-?, inhibits the Jun NH2-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury (2002) Diabetes, 51 (5), pp. 1507-1514; Sidell, R.J., Cole, M.A., Draper, N.J., Desrois, M., Buckingham, R.E., Clarke, K., Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart (2002) Diabetes, 51 (4), pp. 1110-1117; Takano, H., Nagai, T., Asakawa, M., Toyozaki, T., Oka, T., Komuro, I., Saito, T., Masuda, Y., Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor- expression in neonatal rat myocytes (2000) Circ Res, 87, pp. 596-602. , 11009565; Yuan, Z., Liu, Y., Liu, Y., Zhang, J., Kishimoto, C., Wang, Y., Ma, A., Liu, Z., Peroxisome proliferation-activated receptor-? ligands ameliorate experimental autoimmune myocarditis (2003) Cardiovascular Research, 59 (3), pp. 685-694. , DOI 10.1016/S0008-6363(03)00457-7, PII S0008636303004577; Shiomi, T., Tsutsui, H., Hayashidani, S., Suematsu, N., Ikeuchi, M., Wen, J., Ishibashi, M., Takeshita, A., Pioglitazone, a peroxisome proliferator-activated receptor-? agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction (2002) Circulation, 106 (24), pp. 3126-3132. , DOI 10.1161/01.CIR.0000039346.31538.2C; Wayman, N.S., Hattori, Y., Mcdonald, M.C., Mota-Filipe, H., Cuzzocrea, S., Pisano, B., Chatterjee, P.K., Thiemermann, C., Ligands of the peroxisome proliferator-activated receptors (PPAR-? and PPAR-?) reduce myocardial infarct size (2002) FASEB Journal, 16 (9), pp. 1027-1040. , DOI 10.1096/fj.01-0793com; Yue, T.-L., Chen, J., Bao, W., Narayanan, P.K., Bril, A., Jiang, W., Lysko, P.G., Ohlstein, E.H., In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-? agonist rosiglitazone (2001) Circulation, 104 (21), pp. 2588-2594; Meigs, J.B., Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors (2000) Am J Epidemiol, 152, pp. 908-12. , 10.1093/aje/152.10.908. 11092432; Sakkinen, P.A., Wahl, P., Cushman, M., Lewis, M.R., Tracy, R.P., Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome (2000) Am J Epidemiol, 152, pp. 897-907. , 10.1093/aje/152.10.897. 11092431; Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Bonadonna, R.C., Muggeo, M., Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: Prospective data from the Bruneck Study (2003) Diabetes Care, 26 (4), pp. 1251-1257. , DOI 10.2337/diacare.26.4.1251; Reilly, M.P., Wolfe, M.L., Rhodes, T., Girman, C., Mehta, N., Rader, D.J., Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis (2004) Circulation, 110 (7), pp. 803-809. , DOI 10.1161/01.CIR.0000138740.84883.9C; Iwasaki, Y., Asai, M., Yoshida, M., Nigawara, T., Kambayashi, M., Oiso, Y., Nakashima, N., Nilvadipine inhibits nuclear factor-?B-dependent transcription in hepatic cells (2004) Clinica Chimica Acta, 350 (1-2), pp. 151-157. , DOI 10.1016/j.cccn.2004.07.012, PII S0009898104003730; Chen, Y.G., Xu, F., Zhang, Y., Ji, Q.S., Sun, Y., L�, R.J., Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome (2006) Chin Med J, 119, pp. 32-36. , 16454979; Sun, M., Dawood, F., Wen, W.-H., Chen, M., Dixon, I., Kirshenbaum, L.A., Liu, P.P., Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction (2004) Circulation, 110 (20), pp. 3221-3228. , DOI 10.1161/01.CIR.0000147233.10318.23; Valgimigli, M., Ceconi, C., Malagutti, P., Merli, E., Soukhomovskaia, O., Francolini, G., Cicchitelli, G., Ferrari, R., Tumor necrosis factor-? receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study (2005) Circulation, 111 (7), pp. 863-870. , DOI 10.1161/01.CIR.0000155614.35441.69; Wada, H., Saito, K., Kanda, T., Kobayashi, I., Fujii, H., Fujigaki, S., Tumor necrosis factor- plays a role in actual viral myocarditis in mice (2001) Circulation, 103, pp. 743-749. , 11156888; Li, W., Gan, R., Sun, G., Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling (2002) Chinese Medical Journal, 115 (8), pp. 1166-1169; Mann, D.L., McMurray, J.J.V., Packer, M., Swedberg, K., Borer, J.S., Colucci, W.S., Djian, J., Fleming, T., Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) (2004) Circulation, 109 (13), pp. 1594-1602. , DOI 10.1161/01.CIR.0000124490.27666.B2; McKarns, S.C., Schwartz, R.H., Distinct effects of TGF-?1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: A role for T cell intrinsic Smad3 (2005) Journal of Immunology, 174 (4), pp. 2071-2083; Cheung, P.-Y., Sawicki, G., Wozniak, M., Wang, W., Radomski, M.W., Schulz, R., Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart (2000) Circulation, 101 (15), pp. 1833-1839; Lalu, M.M., Pasini, E., Schulze, C.J., Ferrari-Vivaldi, M., Ferrari-Vivaldi, G., Bachetti, T., Schulz, R., Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart (2005) European Heart Journal, 26 (1), pp. 27-35. , DOI 10.1093/eurheartj/ehi007; Mujumdar, V.S., Smiley, L.M., Tyagi, S.C., Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength (2001) International Journal of Cardiology, 79 (2-3), pp. 277-286. , DOI 10.1016/S0167-5273(01)00449-1, PII S0167527301004491; Jugdutt, B.I., Ventricular remodeling after infarction and the extracellular collagen matrix: When is enough enough? (2003) Circulation, 108 (11), pp. 1395-1403. , DOI 10.1161/01.CIR.0000085658.98621.49; Xing, S., Tan, H., Bi, X., Zhong, M., Zhang, Y., Zhang, W., Felodipine Reduces Cardiac Expression of IL-18 and Perivascular Fibrosis in Fructose-Fed Rats (2008) Mol Med, 14 (7-8), pp. 395-402. , 10.2119/2008-00024.Xing. 18504504; Zhang, M., Lv, X.Y., Li, J., Xu, Z.G., Chen, L., The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model (2008) Exp Diabetes Res, p. 704045. , 19132099; Waynforth, H.B., Flecknell, P.A., (1998) Experimental and Surgical Technique in the Rat, pp. 66-113. , Academic Press London 2; Melin, J., Hellberg, O., Akyurek, L.M., Kallskog, O., Larsson, E., Fellstrom, B.C., Ischemia causes rapidly progressive nephropathy in the diabetic rat (1997) Kidney International, 52 (4), pp. 985-991; Johns, D.G., Ao, Z., Eybye, M., Olzinski, A., Costell, M., Gruver, S., Smith, S.A., Macphee, C.H., Rosiglitazone protects against ischemia/reperfusion-induced leukocyte adhesion in the Zucker diabetic fatty rat (2005) Journal of Pharmacology and Experimental Therapeutics, 315 (3), pp. 1020-1027. , http://jpet.aspetjournals.org/cgi/reprint/315/3/1020, DOI 10.1124/jpet.105.090993; Xing, S., Tan, H., Bi, X., Zhong, M., Zhang, Y., Zhang, W., Felodipine Reduces Cardiac Expression of IL-18 and Perivascular Fibrosis in Fructose-Fed Rats (2008) Mol Med, 14 (7-8), pp. 395-402. , 10.2119/2008-00024.Xing. 18504504; Basile, D.P., Martin, D.R., Hammerman, M.R., Extracellular matrix-related genes in kidney after ischemic injury: Potential role for TGF-? in repair (1998) Am J Physiol Renal Physiol, 275, pp. 6894-F903; Drury, R.A., Wallington, E.A., (1980) Histological Techniques, pp. 27-29. , Oxford University press. Oxford, N.Y., Toronto 5; Bancroft, J., (1982) Theory and Practice of Histological Techniques, pp. 131-135; Braham, D., Trinder, P., An improved colour reagent for the determination of blood glucose by the oxidase system (1972) Analyst, 97, pp. 142-145. , 10.1039/an9729700142. 5037807; Nagele, U., Hagele, E.O., Sauer, G., Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency (1984) Journal of Clinical Chemistry and Clinical Biochemistry, 22 (2), pp. 165-174; Fascse, C.F., Enzymatic colorimetric method determination of total cholesterol in human serum (1982) Clin Chem, 28, pp. 901-907; Warnick, G.R., Benderson, J., Albers, J.J., Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol (1982) Clinical Chemistry, 28 (6), pp. 1379-1388; Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge (1972) Clin Chem, 18 (6), pp. 499-502. , 4337382; Bonavida, B., Immunomodulatory effect of tumor necrosis factor (1991) Biotherapy, 3, pp. 127-33. , 10.1007/BF02172085. 2054253; Nathan, D.M., Davidson, M.B., DeFronzo, R.A., Heine, R.J., Henry, R.R., Pratley, R., Zinman, B., Kahn, R., Impaired fasting glucose and impaired glucose tolerance: Implications for care (2007) Diabetes Care, 30 (3), pp. 753-759. , http://care.diabetesjournals.org/cgi/reprint/30/3/753.pdf, DOI 10.2337/dc07-9920; Yanagawa, T., Taniguchi, A., Fukushima, M., Nakai, Y., Nagasaka, S., Ohgushi, M., Matsumoto, K., Seino, Y., Leptin, triglycerides, and interleukin 6 are independently associated with C-reactive protein in Japanese type 2 diabetic patients (2007) Diabetes Research and Clinical Practice, 75 (1), pp. 2-6. , DOI 10.1016/j.diabres.2006.04.019, PII S0168822706001732; Trichon, B., Roe, M., Diabetes mellitus and ischemic heart disease (2004) Diabetes and Cardiovascular Disease: Integrating Science and Clinical Medicine, pp. 241-250. , Marso PS, Stern MD Lippincott Williams and Wilkins; Cefalu, W.T., Insulin resistance: Cellular and clinical concepts (2001) Exp Biol Med, 226, pp. 13-26; Ares-Carrasco, S., Picatoste, B., Benito-Mart�n, A., Zubiri, I., Sanz, A.B., Snchez-N?o, M.D., Ortiz, A., Lorenzo, O., Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes (2009) Am J Physiol Heart Circ Physiol, 297, pp. 82109-H2119. , 10.1152/ajpheart.00157.2009. 19820199; Akbarzadeh, A., Norouzian, D., Mehrabi, M.R., Jamshidi, Sh., Farhangi, A., Allah Verdi, A., Mofidian, S.M.A., Lame Rad, B., Induction of diabetes by Streptozotocin in rats (2007) Indian Journal of Clinical Biochemistry, 22 (2), pp. 60-64. , http://medind.nic.in/iaf/t07/i2/iaft07i2p60.pdf, DOI 10.1007/BF02913315; El-Batran, S.A., Abdel-Salam, O.M.E., Nofal, S.M., Baiuomy, A.R., Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or in combination with the biguanide metformin in diabetic rats (2006) Pharmacological Research, 53 (1), pp. 69-74. , DOI 10.1016/j.phrs.2005.08.008, PII S104366180500160X; Qian, Y., Li, S., Ye, S., Chen, Y., Zhai, Z., Chen, K., Yang, G., Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats (2008) J Endocrinol Invest, 31, pp. 1069-1074. , 19246972; Abu-Abeeleh, M., Bani Ismail, Z., Alzaben, K.R., Abu-Halaweh, S.A., Al Essa, M.K., Abu-Abeeleh, J., Alsmady, M.M., Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: A comparison between 2 strains of rats (2009) Eur J Nephrol, 24, pp. 46-53; Grossman, E., Messerli, F.H., Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory Facets (2008) Adv Cardiol Basel, Karger, 45, pp. 82-106. , full-text; Wilson, P.W., D'Agostino, R.B., Sullivan, L., Parise, H., Kannel, W.B., Overweight and obesity as determinants of cardiovascular risk: The Framingham experience (2002) Arch Intern Med, 162, pp. 1867-1872. , 10.1001/archinte.162.16.1867. 12196085; Snow, V., Aronson, M.D., Hornbake, E.R., Mottur-Pilson, C., Weiss, K.B., Lipid Control in the Management of 2 Diabetes Mellitus: A Clinical Practice Guideline from the American College of Physicians (2004) Annals of Internal Medicine, 140 (8), pp. 644-649; Treatment of Hypertension in Adults with Diabetes (2003) Diabetes Care, 26 (SUPPL. 1), pp. 1980-s82. , American Diabetes Association 12502624; Aronson, D., Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes (2003) Journal of Hypertension, 21 (1), pp. 3-12. , DOI 10.1097/00004872-200301000-00002; Asbun, J., Villarreal, F.J., The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy (2006) Journal of the American College of Cardiology, 47 (4), pp. 693-700. , DOI 10.1016/j.jacc.2005.09.050, PII S0735109705027476; Shiomi, T., Tsutsui, H., Ikeuchi, M., Matsusaka, H., Hayashidani, S., Suematsu, N., Wen, J., Takeshita, A., Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction (2003) Journal of the American College of Cardiology, 42 (1), pp. 165-172. , DOI 10.1016/S0735-1097(03)00509-6; Backlund, T., Palojoki, E., Saraste, A., Eriksson, A., Finckenberg, P., Kyto, V., Lakkisto, P., Tikkanen, I., Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes (2004) Diabetologia, 47 (2), pp. 325-330. , DOI 10.1007/s00125-003-1311-5; Opara, E.C., Oxidative stress, micronutrients, diabetes mellitus and its complications (2002) Journal of The Royal Society for the Promotion of Health, 122 (1), pp. 28-34; Waller, D.G., Renwick, A.G., Hillier, K., Ischemic Heart Disease (2001) Medical Pharmacology and Therapeutics, 5, p. 81. , W.B.Saunders; Spain; Winer, N., Sowers, J.R., Epidemiology of Diabetes (2004) Journal of Clinical Pharmacology, 44 (4), pp. 397-405. , DOI 10.1177/0091270004263017; Waller, D.G., Renwick, A.G., Hillier, K., Ischemic Heart Disease (2001) Medical Pharmacology and Therapeutics, 5, p. 81. , WB Saunders; Spain; Opie, L.H., Clinician Update; Metabolic Syndrome (2007) Circulation, 115, pp. 532-e35. , 10.1161/CIRCULATIONAHA.106.671057. 17242286; Sampson, M., Davies, I., Gavrilovic, J., Sussams, B., Brown, J., Astley, S., Hughes, D.A., Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes (2004) Cardiovasc Diabetol, 3 (1), p. 7. , 10.1186/1475-2840-3-7. 15207013; Gao, X., Picchi, A., Zhang, C., Upregulation of TNF-alpha and Receptors Contribute to Endothelial Dysfunction in Zucker Diabetic Rats (2010) Am J Biomed Sci, 2 (1), pp. 1-12. , 10.5099/aj100100001. 20559450; Dinh, W., F�th, R., Nickl, W., Krahn, T., Ellinghaus, P., Scheffold, T., Bansemir, L., Lankisch, M., Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders (2009) Cardiovascular Diabetology, 8, p. 58. , 10.1186/1475-2840-8-58. 19909503; Mizushige, K., Yao, L., Noma, T., Kiyomoto, H., Yu, Y., Hosomi, N., Ohmori, K., Matsuo, H., Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model (2000) Circulation, 101 (8), pp. 899-907; Shigeyama, J., Yasumura, Y., Sakamoto, A., Ishida, Y., Fukutomi, T., Itoh, M., Miyatake, K., Kitakaze, M., Increased gene expression of collagen Types I and III is inhibited by ?-receptor blockade in patients with dilated cardiomyopathy (2005) European Heart Journal, 26 (24), pp. 2698-2705. , DOI 10.1093/eurheartj/ehi492; Filippi, C.M., Juedes, A.E., Oldham, J.E., Ling, E., Togher, L., Peng, Y., Flavell, R.A., Von Herrath, M.G., Transforming Growth Factor- Suppresses the Activation of CD8+ T-Cells When Nave but Promotes Their Survival and Function Once Antigen Experienced (2008) Diabetes, 57 (10), pp. 2684-2692. , 10.2337/db08-0609. 18689691; Lijnen, P.J., Petrov, V.V., Fagard, R.H., Induction of cardiac fibrosis by transforming growth factor-beta (1) (2000) Mol Genet Metab, 71, pp. 418-435. , 10.1006/mgme.2000.3032. 11001836; Martinez, A., Oh, H.-R., Unsworth, E.J., Bregonzio, C., Saavedra, J.M., Stetler-Stevenson, W.G., Cuttitta, F., Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator (2004) Biochemical Journal, 383 (3), pp. 413-418. , DOI 10.1042/BJ20040920; Tsuruda, T., Costello-Boerrigter, L.C., Burnett Jr., J.C., Matrix metalloproteinases: Pathways of induction by bioactive molecules (2004) Heart Failure Reviews, 9 (1), pp. 53-61. , DOI 10.1023/B:HREV.0000011394.34355.bb; Lindsey, M.L., MMP induction and inhibition in myocardial infarction (2004) Heart Failure Reviews, 9 (1), pp. 7-19. , DOI 10.1023/B:HREV.0000011390.44039.b7; Wang, W., Schulze, C.J., Suarez-Pinzon, W.L., Dyck, J.R., Sawicki, G., Schulz, R., Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury (2002) Circulation, 106, pp. 1543-9. , 10.1161/01.CIR.0000028818.33488.7B. 12234962 |
|